DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
Conditions
Penile Squamous Cell Carcinoma (PSCC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Universitätsklinikum Carl Gustav Carus, Dresden, Germany
Contact: Principal Investigator (Christian Thomas, Prof. Dr.)University Hospital and Medical Faculty, Heinrich-Heine-University, Düsseldorf, Düsseldorf, Germany
Contact: Principal Investigator (Günter Niegisch, Prof. Dr.)University Medical Center of Johannes Gutenberg-University, Mainz, Germany
Contact: Principal Investigator (Anita Thomas, PD Dr.)University Hospital Mannheim, Mannheim, Germany
Contact: Principal Investigator (Benjamin Meister, Dr.)Technical University of Munich, University Hospital Munich, Munich, Germany
Contact: Principal Investigator (Margitta Retz, Prof. Dr.)Caritas St. Josef Medical Center, Regensburg, Germany
Contact: Principal Investigator (Marco Schnabel, PD Dr.)Rostock University Medical Center, Rostock, Germany
Contact: Principal Investigator (Angelika Borkowetz, Prof. Dr.)University Hospital Tübingen, Tübingen, Germany
Contact: Study coordinator (Igor Tsaur, Prof. Dr.)Contact: Principal Investigator (Igor Tsaur, Prof. Dr.)
Study leads
Salah-Eddin Al-Batran, Prof. Dr.
Study Chair
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest